Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

Similar articles for PubMed (Select 24250787)

1.

Impact of polymorphic variants on the molecular pharmacology of the two-agonist conformations of the human β1-adrenoceptor.

Baker JG, Proudman RG, Hill SJ.

PLoS One. 2013 Nov 8;8(11):e77582. doi: 10.1371/journal.pone.0077582. eCollection 2013.

2.

Identification of key residues in transmembrane 4 responsible for the secondary, low-affinity conformation of the human β1-adrenoceptor.

Baker JG, Proudman RG, Hill SJ.

Mol Pharmacol. 2014 May;85(5):811-29. doi: 10.1124/mol.114.091587. Epub 2014 Mar 7.

4.

The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor.

Baker JG, Proudman RG, Tate CG.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Jul;384(1):71-91. doi: 10.1007/s00210-011-0648-4. Epub 2011 May 6.

5.

Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking.

Rathz DA, Brown KM, Kramer LA, Liggett SB.

J Cardiovasc Pharmacol. 2002 Feb;39(2):155-60.

PMID:
11791000
6.
7.
8.

Human heart beta-adrenoceptors: beta1-adrenoceptor diversification through 'affinity states' and polymorphism.

Molenaar P, Chen L, Semmler AB, Parsonage WA, Kaumann AJ.

Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1020-8. Review.

PMID:
17714089
10.

A gain-of-function polymorphism in a G-protein coupling domain of the human beta1-adrenergic receptor.

Mason DA, Moore JD, Green SA, Liggett SB.

J Biol Chem. 1999 Apr 30;274(18):12670-4.

11.

Site of action of beta-ligands at the human beta1-adrenoceptor.

Baker JG.

J Pharmacol Exp Ther. 2005 Jun;313(3):1163-71. Epub 2005 Feb 16.

12.

Evidence for a secondary state of the human beta3-adrenoceptor.

Baker JG.

Mol Pharmacol. 2005 Dec;68(6):1645-55. Epub 2005 Aug 29.

13.

Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.

Taira CA, Carranza A, Mayer M, Di Verniero C, Opezzo JA, Höcht C.

Curr Clin Pharmacol. 2008 Sep;3(3):174-84. Review.

PMID:
18781904
14.

The beta-adrenergic receptors.

Wallukat G.

Herz. 2002 Nov;27(7):683-90. Review.

PMID:
12439640
15.

Role of key transmembrane residues in agonist and antagonist actions at the two conformations of the human beta1-adrenoceptor.

Baker JG, Proudman RG, Hawley NC, Fischer PM, Hill SJ.

Mol Pharmacol. 2008 Nov;74(5):1246-60. doi: 10.1124/mol.108.048371. Epub 2008 Aug 7.

16.

Temporal analysis of mRNA and miRNA expression in transgenic mice overexpressing Arg- and Gly389 polymorphic variants of the β1-adrenergic receptor.

Dockstader K, Nunley K, Karimpour-Fard A, Medway A, Nelson P, Port JD, Liggett SB, Bristow MR, Sucharov CC.

Physiol Genomics. 2011 Dec 5;43(23):1294-306. doi: 10.1152/physiolgenomics.00067.2011. Epub 2011 Sep 27.

18.

Beta 1- and beta 2-adrenoceptor polymorphisms and cardiovascular diseases.

Leineweber K, Heusch G.

Br J Pharmacol. 2009 Sep;158(1):61-9. doi: 10.1111/j.1476-5381.2009.00187.x. Epub 2009 May 5. Review.

19.

The beta-adrenoceptor.

Johnson M.

Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 3):S146-53. Review.

PMID:
9817738
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk